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ABSTRACT 
BACKGROUND: AKI is associated with high mortality and the optimal time to start RRT for 
AKI is unknown despite several Randomised Controlled Trials (RCTs) on the subject.  We 
performed a systematic review and meta-analysis to assess the effect of earlier initiation of 
Renal Replacement Therapy (RRT) for Acute Kidney Injury (AKI) on mortality and reported 
secondary outcomes.  
METHODS: All literature in databases EMBASE, MEDLINE and CENTRAL was searched 
from January 1970 to March 2019 using terms related to renal replacement therapy, timing 
and randomised controlled trials (RCTs).  All RCTs with 25 or more adult participants suf-
fering from AKI comparing timing of RRT were included.  The selected studies’ results were 
pooled and expressed in terms of risk ratios (RR) and 95% confidence intervals (95% CI) 
using a random effects model.   
RESULTS: 7008 records were identified.  94 were selected for full text review of which 10 
were included in the final meta-analysis.  The ten studies comprised 1956 participants (989 
‘early’ group; 967 ‘late’ group) with 918 total deaths; the analysis demonstrated no significant 
differences between the “early” and “late” RRT groups (RR=0.98 (95% CI=0.84,1.15)) for 
mortality.  No significant differences between groups were evident for period-wise mortality, 
dialysis dependence, recovery of renal function, length of ICU or hospital stay, or number of 
RRTs, mechanical ventilation and vasopressor free days.  
CONCLUSIONS: Current evidence does not support the use of early RRT for patients with 
AKI.  Data from ongoing and future RCTs is required to strengthen the evidence base in the 
area. 
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INTRODUCTION 
Acute Kidney Injury (AKI) is common within the critically ill and hospitalised patients.  AKI, 
an evolution of the term Acute Renal Failure (ARF) has been subject to several classifica-
tions [1-3], making the reported incidence of AKI in patients admitted to Intensive Care Units 
(ICU) vary significantly (35%-67%) [4-7]. Owing to the high incidence within the critically ill, 
an increase in the severity of AKI is associated with increasing all-cause mortality of up to 
57% [6-8]. 
 
Renal Replacement Therapy (RRT) is a key strategy in the treatment of severe AKI with life 
threatening complications such as refractory hyperkalaemia, metabolic acidosis and volume 
overload unresponsive to medical therapy.  Whilst RRT is accepted as an impactful treat-
ment, its implementation remains a matter of debate.  Studies have compared differences 
between modalities of RRT such as intermittent haemo-dialysis vs continuous renal replace-
ment therapy [9,10], hemofiltration vs haemo-dialysis [11], or dose [12]. 
 
Further, the timing to initiate RRT for AKI remains a challenge.  Many Randomised Con-
trolled Trials (RCTs) have been executed to determine whether “early” compared to “de-
layed” initiation is of benefit; two studies [13,14] reported evidence on the subject in 2016, 
followed by several meta-analyses [15-17].  However, a disparity between conclusions per-
sists, with reports that no difference is evident between groups [16,17] whilst others con-
clude that earlier initiation of RRT conveys a decrease in mortality [18,19].  Three subse-
quent RCTs published in 2018 added further data [20-22]. A Cochrane Review was also 
published but excluded studies of patients not admitted to ICU [23]. 
 
Our objective was to conduct a systematic review and meta-analysis on all patients suffer-
ing from AKI who required RRT.  Analysis would be carried out on studies comparing 
  4 
timing of the initiation of RRT in two groups of patients: the first group classified as “early” 
and the second group classified as “late”, “delayed” or “standard treatment”. The studies 
must report on all-cause mortality to be included in the analysis.  We specifically add the 
three RCTs published in 2018 to update previous meta-analyses and assess what this 
new data contributes to this area of study.  
 
METHODS 
Registration  
The review is registered with PROSPERO’s Register of Systematic Reviews, ID Number: 
CRD42019145074.  
https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42019145074 
 
Eligibility Criteria 
The inclusion criteria follow agreed RCT guidelines on reporting differences in the timing of 
initiating RRT (early vs late, standard vs early, early vs delayed).  Non-RCTs, the pediatric 
population and patient population without AKI were excluded. No guidelines as to defining 
RRT timing exist, therefore the definition of ‘early’ and ‘late’ is according to the individual 
studies’ interpretation unless the definition of ‘late’ was outwith that considered a ‘standard’ 
RRT initiation which has resulted in two ‘early’ group classifications. Studies that defined the 
‘late’ group as initiation within 12 hours of diagnosis with any stage AKI were also excluded. 
 
Search Strategy  
Three databases (EMBASE, MEDLINE and Cochrane Central Register of Controlled Trials 
(CENTRAL)) were interrogated for the period January 1974 to March 2019. The search 
strategy was as broad as possible to capture all RCTs conducted on the subject; the only 
filter applied was to restrict results to English language.  MEDLINE and CENTRAL searches 
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used MeSH terms (Figure s1.1).  A near identical search interrogated EMBASE, but with 
certain terms altered to match Emtree headings (Figure s1.2).  In order to identify ongoing 
or not published completed trials, the International Trials Registry (https://www.who.int/ic-
trp/en/) and the National Institutes of Health’s registry (https://www.clinicaltrials.gov) were 
searched. 
 
Study Selection 
Two authors (MA,RS) independently compiled a list of citations gathered from the three 
sources.  Obvious duplicate citations were removed by databases when merging however 
if any two citations had discrepancies, they were both retained for title review.  Both authors 
reviewed the titles independently and selected eligible studies for abstract review; a thor-
ough abstract review was then conducted to select studies eligible for full text review.  A 
concluding, full text review was then executed and any differences between the two review-
ers were referred to a third reviewer (KP) to make a final decision on eligibility. 
 
Data Extraction 
The papers were each initially assessed for time-period mortality reported on and then the 
data were recorded independently using a pre-defined form.  Two independent reviewers 
(MA,RS) extracted key data including the number of patients recruited, definition of “early” 
and “late” RRT groups and measured outcomes. After consolidation, data on the number of 
events and the total for both ‘early’ and ‘late’ groups were collected and outcomes in terms 
of mean, median, mode and interquartile ranges were extracted as reported.   
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Outcome Measures  
The following outcomes were extracted; 
 
Primary Outcomes 
Overall mortality rate, in-ICU, in-hospital, 28-day, 60-day and 90-day mortality rates. 
 
Secondary Outcomes 
Dialysis dependence at 90 days, 28 days and 60 days, recovery of renal function (return to 
baseline) at 90 days, adverse events, length of ICU stay, length of hospital stay, number of 
RRT days, number of RRT free days, number of mechanical ventilation free days, number 
of vasopressor free days. 
 
Risk of Bias 
Each study was assessed independently by two authors (MA,RS) for potential risk of bias 
using the 7 domains cited in the Cochrane Collaboration’s tool [24]; a funnel plot categorised 
the risk of publication bias across the studies. The quality of evidence for the primary out-
comes were assessed independently using the GRADE tool [25]. 
 
Data Synthesis 
The results were expressed in terms of Risk Ratio (RR) and 95% Confidence Intervals (95% 
CI) for mortality and secondary outcomes. Heterogeneity between studies was determined 
through the I2 statistic; a value of >40% was interpreted as a significant degree of heteroge-
neity.  RR for each outcome was estimated using both fixed and random effects to surface 
high degrees of heterogeneity between studies.  Statistical comparison was captured as a 
p-value for each analysis; a value of <0.05 was considered statistically significant.  Any 
outcome reported in terms of continuous data was expressed in terms of pooled raw 
  7 
differences between the two groups medians (a negative difference favouring early RRT) 
and 95% CIs.  This has been previously described as comparing favorably to methods which 
transform medians and IQRs to mean and standard deviation [26].  All data were analysed 
using the software R (R version 3.5.1, The R Foundation).   
 
The following pre-defined sub-groups were analysed for overall mortality to assess possible 
sources of heterogeneity including risk of bias, RRT modality, severity of illness and patient 
population; 
 
• Low risk vs high or unclear risk of bias 
• Intermittent haemo-dialysis vs continuous renal replacement therapy vs mixed 
• ICU only population vs mixed population 
• Medical vs surgical vs mixed patients 
 
RESULTS 
Selected Studies 
The literature search returned a total 7008 references after duplicate removal (Figure 1).  
The features of the ten studies selected for inclusion in the review are detailed in Table 1; 
studies varied in size from 28 patients [29] to 488 patients [22]. Of the ten, eight included 
ICU patients only.   
 
Overall mortality 
The ten studies comprising 1956 patients reported on overall all-cause mortality at varying 
times: 989 into the ‘early’ and 967 into the ‘late’ groups. 918 deaths were reported; 459 in 
the ‘early’ and 459 in the ‘late’ group, corresponding to a mortality rate of 46.4% for patients 
receiving early and 47.5% for those receiving conventional/late RRT.  
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Figure 2 illustrates results from the ten studies depicting no significant difference between 
‘early’ or ‘late’ initiation of RRT for mortality rates: RR=0.98 (95% CI=0.84,1.15 (random 
effects modelling)).  A marked heterogeneity between studies was evident with an I2 of 46% 
(p=0.05).  Pre-defined subgroup analyses were carried out to further explore the possible 
cause.   
 
Impact on Mortality after accounting for risk of bias 
Two studies were assessed to have either a high or unclear risk of bias (Table s1.1), and 
their pooled results suggested a mortality benefit for ‘early’ RRT (Figure s1.3); RR=0.37 
(95% CI=0.08,1.65).  The remaining eight studies were assessed as low risk of bias, with 
pooled results showing no statistically significant difference between groups; RR=1.00 (95% 
CI=0.89,1.13).  The heterogeneity in the low risk of bias group decreased to I2 of 23% (from 
the overall analysis value of 46%).  
 
Impact on mortality after accounting for RRT Modality 
The RRT modality used to deliver the intervention and its impact on mortality is presented 
in Figure s1.4; two studies used intermittent haemodialysis with no significant difference 
between the ‘early’ and ‘late’ arms: RR=1.30 (95% CI=0.63,2.70); four used only continuous 
RRT with no significant difference between groups: RR=0.91 (95% CI=0.57,1.46); and the 
remaining four studies utilised a mixture of these two modalities and also found no significant 
difference between groups: RR=0.95 (95% CI=0.81,1.11).   
 
Impact on mortality after consideration of critical illness  
Two studies included all inpatients (Figure s1.5).  The difference between the ‘early’ and 
‘late’ groups was not statistically significant; RR=1.30 (95% CI=0.63,2.70).  The remaining 
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eight studies included ICU patients only with no observable difference between the two 
groups: RR=0.95 (95% CI=0.80,1.12). 
 
Impact on mortality by admission type: Medical vs Surgical vs Mixed Population 
Two studies only involved patients from a medical cohort (Figure s1.6); no differences in 
mortality between the two RRT groups were observed: RR=1.30 (95% CI=0.63,2.70).  Only 
one study used participants from the surgical cohort, the result indicating a mortality benefit 
in the early RRT group: RR=0.17 (95% CI=0.05,0.61).  The remaining seven studies con-
tained a mixed population of patients and no statistical difference existed between groups: 
RR=0.98 (95% CI=0.88,1.10).   
 
Time-based mortality 
All studies reported mortality numbers over differing time periods, sub-categorised into in-
ICU, in-hospital, 28-day, 60-day and 90-day (Figure 3).  ICU mortality was reported by two 
studies; no statistical difference was evident between the two RRT treatment groups: 
RR=1.02 (95% CI=0.66,1.58).  In-hospital mortality was reported by three studies with no 
significant difference between groups: RR=1.16 (95% CI=0.84,1.60).  Six reported 28-day 
mortality with no significant difference found: RR=0.99 (95% CI=0.88,1.11).  Two reported 
60-day mortality with no significant difference observed: RR=0.89, 95% CI=0.71,1.12).  
Three reported 90-day mortality with no statically significant difference between early and 
late groups: RR=0.93 (95% CI=0.69,1.23). 
 
Secondary Outcomes 
Dialysis dependence was reported at 28 days, 60 days and 90 days.  Four studies reported 
on rates of dialysis dependence in surviving patients after 90 days (Figure s1.7).  The pooled 
data demonstrated no significant differences between ‘early’ and ‘late’ groups: 16/279 vs 
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18/289 patients (RR=0.87).  Four studies reported on rates of dialysis dependence after 28 
days with no statistically significant difference (Figure s1.8): 65/423 vs 76/425 patients 
(RR=0.84).  Dialysis dependence at day 60 was reported by two studies with a benefit sug-
gested in the early RRT group (Figure s1.5): 14/226 vs 22/214 patients (RR=0.59). 
 
No statistically significant differences between the ‘early’ and ‘late’ groups was observable 
for all adverse events except catheter related complications; the results of these can be 
found in Table 2 with forest plots presented in Figure s1.9 – Figure s1.17.  Analysis of the 
six studies reporting catheter related complications (Figure s1.18) suggested an increase in 
complications within the ‘early’ group: RR=1.85 (95% CI=1.18,2.88).   
 
Two studies [13,28] reported median and interquartile values as two separate classes for 
early RRT. In [28], the ‘early’ group was segmented into high- and low-volume haemofiltra-
tion; in [13], values were given for survivors/non-survivors in both ‘early’ and ‘late’ groups; 
these two studies were excluded from the analysis since no composite values were reported.  
In the remaining four studies [14,21,22,31], medians and interquartile ranges were pooled, 
showing no statistically significant difference between the ‘early’ and ‘late’ groups for either 
length of ICU stay (estimated difference in length of stay = 0.34 days (95% CI -1.60,2.28, 
p=0.73)), or length of hospital stay (estimated difference in length of stay = -1.75 days (95% 
CI -5.84,2.34, p=0.40)). 
 
Three studies reported on the impact of the number of RRT days. One study [30] reported 
in terms of mean, +/- SD and therefore was excluded; the other two reporting in terms of 
median and interquartile ranges [14,22].  Although a large estimated difference in medians 
was evident, they were considered statistically insignificant; estimated difference = -5.99 
(95% CI -23.52,11.53, p=0.50); this was also the case for number of mechanical ventilation 
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free days (estimated difference in length of stay = 6.94 days (95% CI -4.59,18.48, p=0.24)).  
No clear difference between groups in terms of the number of RRT free days (estimated 
difference in length of stay = -1.33 days (95% CI -3.66,1.01, p=0.27)), or vasopressor free 
days (estimated difference in length of stay = -0.45 days (95% CI -3.22,2.32, p=0.75)) was 
observable. 
 
Risk of bias across studies 
The risk of bias was estimated through a funnel plot using the overall mortality as an out-
come. The inverted standard error against the RR is shown in Figure s1.19, where the ‘dot-
ted’ lines signify the expected distribution of the studies.  One study [29] is a significant 
outlier; otherwise distributions corroborate a reduced risk of bias across the selected stud-
ies.   
 
DISCUSSION 
The systematic literature review identified a total of ten studies that describe the impact of 
early versus conventional/late RRT on mortality. Whilst the time period for follow-up varied 
throughout, the analysis showed no statistically significant difference in terms of overall, in-
ICU, in-hospital, 28-day, 60-day and 90-day mortality.  Further, subgroup analyses detected 
no significant differences between modality of RRT, or general hospital inpatients vs ICU 
patients only.  
 
On removal of studies with a high or unclear risk of bias, the heterogeneity reduced (I2 from 
46% to 23%), but with no impact on the difference in mortality between groups, suggesting 
these studies are likely to have influenced the consistency of the overall analysis.   
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The only subgroup that identified a difference in outcome as a function of RRT initiation was 
the surgical only population where ‘early’ RRT resulted in an improvement in mortality.  How-
ever, it must be noted that the conclusion was based on a single, small study [29] which 
reported vastly different mortality rates between the ‘early’ and ‘late’ groups (14.29% vs 
85.71%).  The study was the smallest included in the present meta-analysis (n=28) and   
owing to its limited extent, the impact of a few additional patients will markedly alter the 
statistical significance between groups.  In addition, the study was also assessed to have 
an overall unclear risk of bias as well as high risk of reporting incomplete outcome data; 
therefore it is likely that the study with a purely surgical population has skewed results sig-
nificantly.  However, it should be noted that whilst limited conclusions can be drawn, this 
may indeed represent a difference based on patient population and that further studies may 
provide better understanding. 
 
The meta-analysis did not identify any association between timing of RRT for AKI and dial-
ysis dependence at 28 or 90 days but it should be noted that absolute numbers were small.  
Although results from two studies [13,14] investigating dependence at day 60 suggested a 
benefit in the early group, fewer studies reported day 60 compared to day 28 and 90.  In 
both studies, the absolute numbers of dialysis dependent patients at 60 days were relatively 
small which potentially skew the conclusions drawn.  Further, [14] also reported on dialysis 
dependence at day 90 with no significant difference between the groups.  Other reported 
secondary outcomes such as renal recovery, length of ICU stay, length of hospital stay, 
number of RRT days, RRT free days, mechanical ventilation free days and vasopressor free 
days also showed no statistically significant differences between groups. 
 
The pooled results of the majority of adverse events showed no significant difference be-
tween groups with the exception of one: higher rates of catheter related complications were 
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seen in the ‘early’ group which is likely due to the increased number of catheters inserted 
compared to the ‘late’ group. 
 
The variability in the classification of ‘early’ and ‘late’ contribute to increasing the difficulty in 
pooling data for direct comparisons.  Recent studies for the early group [13,14,20,21,22,31] 
have adopted a time frame from eligibility whilst others utilised physiological variables to 
determine the initiation of RRT.  Timeframes ranged from commencement within 6-12 hour 
window from meeting eligibility criteria, whereas physiological criteria ranged from varying 
urine outputs to serum creatinine or urea levels.  In addition to the difference between timing 
vs physiological factors, studies utilising international guidelines for either inclusion or to 
determine commencement of early RRT used varying classifications [1-3].  Whilst a known 
factor prior to devising the search strategy, it was nevertheless deemed that that a system-
atic comparison of differing strategies would be informative despite the paucity of available 
data. 
 
The value of initiating RRT earlier has been subject to extensive debate, and whilst theoret-
ical benefits have been postulated such as limiting fluid overload and organ dysfunction as 
well as removal of inflammatory mediators [32], the hypothesis has not been supported 
through an assessment of measured patient outcomes.  Initiation of RRT at an earlier stage 
will also result in a higher proportion of patients receiving RRT which may in turn result in 
higher rates of complications as well as significant increases to cost. 
   
Previous meta-analyses have reached differing conclusions; two conducted prior to the 
RCTs from 2013, suggested that ‘early’ RRT may convey a mortality benefit [18,19].  In 
contrast, more recent RCTs concluded that there was no difference in mortality between 
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groups [16,17].  In 2018, three further RCTs [20-22] concluded no difference of note in mor-
tality; the large IDEAL-ICU trial [22] was stopped early due to futility. 
 
Evidence drawn from the pooling of studies tends to indicate little significant differences 
exist between early and late initiation of RRT for AKI.  In addition, with the exception of 28-
day mortality which was found to be of moderate quality, all pooled primary outcomes as-
sessed using the GRADE tool were found to be of low quality (Table s1.2).  The currently 
ongoing STARRT-AKI trial [33] will add valuable data in an area where there is still a paucity 
of contextualised data which in turn fuels significant debate. 
 
CONCLUSIONS 
The systematic review and meta-analysis revealed no significant difference between early 
and late initiation of RRT for AKI with regard to the primary outcome of overall mortality and 
multiple secondary outcomes such as length of ICU and hospital stay and dialysis depend-
ence at 90 days.  The agrees with recent previous meta-analyses that current evidence does 
not support the use of early RRT for patients with AKI.  Additional data from ongoing and 
future RCTs is necessary to strengthen the evidence base. 
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Study Setting/ 
Patient 
Group 
Inclusion Criteria Numbers RRT 
Modality 
Early  
Definition for 
RRT 
Late Definition for RRT Outcomes 
Pursnani 
et al. [27] 
(1997) 
Single 
centre; all 
inpatients; 
medical 
only 
Diagnosis of Acute Tubular 
Necrosis with serum creatinine 
<7mg% and blood Urea 
<120mg% 
Total = 35 
Early = 18 
Late = 17 
IHD Early hemodi-
alysis (as soon 
as met eligibil-
ity criteria) 
Conservative management  Overall mortality 
Length of hospital stay 
Adverse events 
Bouman et 
al. [28]* 
(2002) 
Two   
centres, 
single 
country; 
ICU only; 
mixed  
patients 
Urine output <30ml/hr for >6 
hours and creatinine clearance 
<20ml/min 
Total = 106 
Early = 70  
Late = 36 
CRRT RRT started 
within 12 
hours of inclu-
sion 
Plasma Urea level 
>40mmol/l, potassium 
>6.5mmol/l or severe pul-
monary oedema 
ICU, hospital and 28 day  
mortality 
Recovery of renal  
function at 90 days 
Duration of ICU and hospital stay 
Adverse events 
Sugahara 
et al. [29] 
(2004) 
Single 
centre; 
ICU only; 
surgical 
only 
Post CABG patients. Hourly 
urine output <30ml/hr and se-
rum creatinine increased at 
rate of 0.5mg/dL/day or more 
Total = 28 
Early = 14 
Late = 14 
CRRT Urine Output 
<30ml/hr for 3 
consecutive 
hours (or daily 
urinary output 
750ml or less) 
Urine output <20ml/hr for 2 
consecutive hours (or daily 
urinary output 500ml or 
less) 
14 day mortality 
Changes in BP, urine output and 
creatinine 
Jamale et 
al. [30] 
(2013) 
Single 
centre; all 
inpatients; 
medical 
only 
Severe AKI with increasing se-
rum urea and creatinine levels  
Total = 208 
Early = 102 
Late = 106 
IHD Serum urea 
>70mg/dL 
and/or creati-
nine level 
>7mg/dL 
Treatment refractory hy-
perkalaemia, volume over-
load, acidosis. Uremic 
nausea and anorexia with 
inability to maintain oral in-
take 
In hospital mortality 
Dialysis dependence at 90 days 
Number of RRT days 
Adverse events 
Wald et al. 
[31] 
(2015) 
Multiple 
centres, 
single 
country; 
ICU only; 
mixed pa-
tients  
Volume replete severe AKI 
with two criteria from three: 
creatinine doubled from base-
line, urine output <6ml/kg in 
last 12 hours or whole blood 
NGAL >400ng/ml.  Absence of 
urgent indications for RRT. 
Total = 100 
Early = 48 
Late = 52 
Mixed RRT started 
within 12 
hours of ful-
filling eligibility 
criteria 
Potassium >6.0 mmol/l, 
serum bicarbonate <10 
mmol/l, PaO2/FiO2 <200 
with infiltrates on chest ra-
diograph suggestive of 
pulmonary oedema 
ICU, hospital and 90 day mortal-
ity 
Dialysis dependence at 90 days 
Length of ICU and hospital stay 
Adverse events 
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Patient 
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Modality 
Early  
Definition for 
RRT 
Late Definition for RRT Outcomes 
Gaudry et 
al. [13] 
(2016) 
Multiple 
centres, 
single 
country; 
ICU only; 
mixed  
patients 
KDIGO [3] stage 3 AKI com-
patible with a diagnosis of is-
chaemic or toxic Acute Tubu-
lar Necrosis and receiving me-
chanical ventilation and/or cat-
echolamine infusion. 
Total = 619 
Early = 311 
Late = 308 
Mixed RRT com-
menced within 
6 hours after 
documentation 
of KDIGO [3] 
stage 3 AKI 
Urea >40 mmol/l, potas-
sium >6 mmol/l (or >5.5 
mmol/l despite medical 
treatment), pH <7.15, pul-
monary oedema due to 
fluid overload requiring ox-
ygen >5 l/ or FiO2 >50%, 
oliguria or anuria >72 
hours 
28 and 60-day mortality 
Dialysis dependence at 28 and 
60 days 
Length of ICU and hospital stay 
Number of RRT, mechanical 
ventilation and vasopressor free 
days 
Zarbock et 
al. [14] 
(2016) 
Single 
centre; 
ICU only; 
mixed  
patients 
KDIGO stage 2 AKI (baseline 
creatinine doubled or urinary 
output <0.5 ml/kg/hr for >12 
hours) despite optimal resusci-
tation, NGAL >150ng/ml and 
one of: severe sepsis, use of 
vasopressors, refractory fluid 
overload and progression of 
non-renal organ dysfunction 
Total = 231 
Early = 112 
Late = 119 
Mixed RRT started 
within 8 hours 
of diagnosis of 
KDIGO stage 
2 AKI 
Commenced within 12 
hours of diagnosis of stage 
3 AKI, or if urea >100 
mg/dL, potassium >6.0 
mmol/l and or ECG 
changes, urine output 
<200ml in 12 hours or or-
gan oedema resistant to 
diuretic treatment 
28, 60 and 90-day mortality 
Dialysis dependence at 28, 60 
and 90 days 
Length of ICU and hospital stay 
Length of mechanical ventilation 
and RRT 
Adverse events 
Srisawat et 
al. [20]^ 
(2018) 
Single 
centre; 
ICU only; 
mixed  
patients 
Patients aged 18 or older diag-
nosed with AKI by RIFLE crite-
ria [1] 
Total = 40 
Early = 20 
Late = 20 
CRRT RRT started 
within 12 
hours of ran-
domization. 
Severe refractory acidosis 
(pH <7.2 or HCO3 <15), 
severe peripheral oedema, 
pulmonary oedema, no re-
sponse to diuretics, refrac-
tory hyperkalaemia (K >6.2 
or ECG changes), anuria 
or oliguria or high BUN 
(>60) 
28-day mortality 
Dialysis dependence at 28 days 
Mechanical ventilation free days 
ICU free days 
Renal Recovery at 28 days 
Balance of input and output fluid  
Lumlertgul 
et al. [21]+ 
(2018) 
 
Multiple 
centres, 
single 
country; 
ICU only; 
mixed  
patients 
AKI with diagnosis of Acute 
Tubular Necrosis, clinically re-
suscitated and euvolaemic, no 
urgent indication or contraindi-
cations for RRT.  
Total = 118 
Early = 58 
Late = 60 
CRRT RRT was 
started in the 
early group 
within 6 hours 
of randomisa-
tion 
Urea >100 mg/dL, potas-
sium >6 mmol/l, serum bi-
carbonate <12 mmol/l, pH 
<7.15, PaO2/FiO2 ratio 
<200 or chest radiographs 
compatible with pulmonary 
oedema 
28-day mortality 
Dialysis dependence and renal 
recovery at 28 days 
Length of ICU and hospital stay 
Number of RRT and mechanical 
ventilation free days 
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Definition for 
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Late Definition for RRT Outcomes 
Barbar et 
al. [22] 
(2018) 
Multiple 
centres, 
single 
country; 
ICU only; 
mixed  
patients 
Early phase of septic shock 
(within 48 hours of start of vas-
opressor therapy) developing 
AKI with at least one criterion 
of the failure stage of the RI-
FLE classification system [1]  
Total = 488 
Early = 246 
Late = 242 
Mixed RRT com-
menced within 
12 hours of 
documentation 
of “failure” 
stage AKI [1] 
RRT commenced 48 hours 
after diagnosis of AKI or if 
prior to this: serum potas-
sium >6.5 mmol/l, pH 
<7.15 or fluid overload with 
pulmonary oedema 
28, 90 and 180 day mortality 
Dialysis dependence at 28 and 
90 days 
Length of ICU and hospital stay 
RRT, mechanical ventilation and 
vasopressor free days 
Adverse events  
Table 1: Study characteristics 
*Patients in early group split into low-volume (n=35) and high-volume (n=35) hemofiltration 
^Patients were tested for plasma neutrophil gelatinase associated lipocalin (pNGAL) levels after recruitment. Patients with pNGAL level 
greater than or equal to 400ng/ml were randomized into early or late groups 
+Patients underwent a furosemide stress test first.  If they were non-responsive they were randomised into early or late groups.   
 
  
  22 
Outcome Number of participants (studies) Risk Ratio 95% Confidence Intervals 
Recovery of renal function to 
baseline at 90 days 
 181 (2 studies) 1.00 0.94 – 1.06 
Bleeding events 1905 (8 studies) 0.80 0.56 – 1.15 
Arrhythmias 1591 (6 studies) 1.11 0.84 – 1.45 
Dialysis related hypotension 1080 (6 studies) 1.14 0.82 – 1.57 
Hypokalaemia 737 (2 studies) 1.04 0.77 – 1.40 
Thrombocytopenia 725 (2 studies) 1.03 0.89 – 1.19 
Hypocalcaemia 449 (3 studies) 1.12 0.92 – 1.36 
Hypophosphatemia 737 (2 studies) 2.68 0.62 – 11.58 
Hyperkalaemia 1107 (2 studies) 0.27 0.01 – 5.85 
Table 2: Summary of secondary outcomes related to adverse events and recovery of renal function at 90 days  
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Figure 1: PRISMA Flow Diagram 
 
Figure 2: Forest plot of the effect of early versus late RRT on overall mortality 
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Figure 3: Impact of early versus late RRT on mortality rates at various time pe-
riods 
 
 
 
 
 
